US agency warns on Globus products:
This article was originally published in Clinica
Executive Summary
Tipped off by consumer complaints, the US FDA has alerted the public not to use home-use diagnostic test kits marketed nationwide via the internet by Globus Media, of Montreal, Canada. The company is marketing a variety of tests, including kits for the detection of HIV, dengue fever and syphilis; those for the presence of cocaine, marijuana or amphetamines; and two pregnancy tests. The use of these products could produce false results (though there is no confirmed evidence of these) that could lead to significant adverse health consequences, the FDA said.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.